LUIS AROSEMENA

SVP, Head of Europe & International

Luis Arosemena is Senior Vice President, Head of Europe & International, bringing over 25 years of experience leading businesses and teams across global markets. Luis joined ViiV Healthcare in 2026.

Prior to joining ViiV Healthcare, Luis held a series of global, regional and country leadership roles at GSK. Early in his career, he held senior commercial leadership positions across Asia Pacific and Latin America, including General Manager assignments and regional marketing leadership roles.

He later served in the CEO’s office as VP, Corporate Strategy, and in 2014 joined GSK’s Vaccines Executive Team as Head of the Global Commercial Organisation. From 2017 to 2020, Luis was General Manager and President of GSK Italy, and a Board member of Farmindustria, local trade association, where he chaired the Prevention Committee. From 2020 to 2025, he led GSK’s Emerging Markets region — the company’s third-largest business unit — spanning Latin America, the Middle East, CIS, Africa and Asia.

From 2025 to 2026, he served as SVP, Global Commercial Strategy, shaping the commercial operating model to accelerate innovation and enhance efficiency through technology and talent.

Luis holds a bachelor’s degree in Business Management from the University of Lima and an MBA from Kellogg School of Management at Northwestern University.

Our Executive Team

Audrey Abernathy, Head of Communications and Government Affairs
Audrey Abernathy

Head of Communications and Government Affairs

Read more
Becky Hall
Becky Hall

Chief Financial Officer

Read more
Jean van Wyk , Chief Medical Officer
Jean van Wyk

Chief Medical Officer

Read more
Jean-Bernard Simeon, SVP and Head of ViiV US
Jean-Bernard Simeon

SVP and Head of ViiV US

Read more
Charlotte Allerton, Board of Directors member, ViiV Healthcare
Charlotte Allerton

Head of Research and Development

Read more
Robert Bowers, Head of Global Commercial Strategy, ViiV Healthcare
Robert Bowers

Head of Global Commercial Strategy

Read more
Crystal Baker, General Counsel and Chief Compliance Officer
Crystal Baker

General Counsel and Chief Compliance Officer

Read more
Luis Arosemena, SVP, Head of Europe & International
Luis Arosemena

SVP, Head of Europe & International

Read more

YOU MAY ALSO BE INTERESTED IN

We are ViiV Healthcare: 100% dedicated to HIV medicines and research and completely focused on people affected by HIV and AIDS. At ViiV Healthcare we do things differently. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care.

We have established to take a fresh approach to the challenge of HIV. We set ourselves one mission - to leave no person living with HIV behind. Our values and expectations are at the heart of everything we do. They are integral to how we conduct our business and form an important part of our culture.

NP-GBL-HVX-COCO-220025 April 2026

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.